Bellevue Group Ag Boston Scientific Corp Transaction History

Bellevue Group Ag

  • $5.98 Billion
  • Q2 2024

A detailed history of Bellevue Group Ag transactions in Boston Scientific Corp stock. As of the latest transaction made, Bellevue Group Ag holds 2,569,588 shares of BSX stock, worth $214 Million. This represents 3.31% of its overall portfolio holdings.

Number of Shares
2,569,588
Previous 3,148,676 18.39%
Holding current value
$214 Million
Previous $216 Million 8.24%
% of portfolio
3.31%
Previous 3.38%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$67.33 - $77.71 $39 Million - $45 Million
-579,088 Reduced 18.39%
2,569,588 $198 Million
Q1 2024

May 15, 2024
SELL
$57.6 - $68.62 $1.26 Million - $1.5 Million
-21,927 Reduced 0.69%
3,148,676 $216 Million
Q4 2023

Feb 14, 2024
BUY
$48.64 - $57.81 $25.5 Million - $30.3 Million
524,308 Added 19.81%
3,170,603 $183 Million
Q3 2023

Nov 14, 2023
SELL
$50.19 - $54.68 $760,729 - $828,784
-15,157 Reduced 0.57%
2,646,295 $140 Million
Q2 2023

Aug 14, 2023
SELL
$49.72 - $54.64 $38.7 Million - $42.5 Million
-778,127 Reduced 22.62%
2,661,452 $144 Million
Q1 2023

May 15, 2023
SELL
$45.09 - $50.03 $20.9 Million - $23.2 Million
-463,345 Reduced 11.87%
3,439,579 $172 Million
Q4 2022

Feb 14, 2023
BUY
$39.56 - $47.22 $3.91 Million - $4.67 Million
98,877 Added 2.6%
3,902,924 $181 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $1.69 Million - $5.06 Million
-46,124 Reduced 1.2%
3,804,047 $147 Million
Q2 2022

Aug 11, 2022
SELL
$35.24 - $47.1 $2.25 Million - $3 Million
-63,776 Reduced 1.63%
3,850,171 $143 Million
Q1 2022

May 13, 2022
BUY
$40.9 - $45.1 $38.9 Million - $42.8 Million
949,916 Added 32.05%
3,913,947 $173 Million
Q4 2021

Feb 10, 2022
SELL
$38.07 - $44.87 $117,864 - $138,917
-3,096 Reduced 0.1%
2,964,031 $126 Million
Q3 2021

Nov 12, 2021
BUY
$41.23 - $45.88 $26.4 Million - $29.4 Million
640,340 Added 27.52%
2,967,127 $129 Million
Q1 2021

May 12, 2021
BUY
$35.27 - $39.67 $4.12 Million - $4.64 Million
116,928 Added 5.29%
2,326,787 $89.9 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $41.97 $10.7 Million - $13.6 Million
323,562 Added 17.15%
2,209,859 $79.4 Million
Q3 2020

Nov 16, 2020
BUY
$34.44 - $42.23 $5.36 Million - $6.57 Million
155,677 Added 9.0%
1,886,297 $72.1 Million
Q2 2020

Aug 13, 2020
BUY
$30.19 - $39.11 $5.72 Million - $7.41 Million
189,395 Added 12.29%
1,730,620 $60.8 Million
Q1 2020

May 14, 2020
SELL
$25.83 - $45.71 $965,938 - $1.71 Million
-37,396 Reduced 2.37%
1,541,225 $50.3 Million
Q4 2019

Feb 14, 2020
BUY
$37.87 - $45.37 $6.01 Million - $7.2 Million
158,633 Added 11.17%
1,578,621 $71.4 Million
Q3 2019

Nov 14, 2019
BUY
$40.31 - $43.45 $1.58 Million - $1.7 Million
39,206 Added 2.84%
1,419,988 $57.8 Million
Q2 2019

Aug 14, 2019
BUY
$34.91 - $42.98 $8.14 Million - $10 Million
233,295 Added 20.33%
1,380,782 $59.3 Million
Q1 2019

May 15, 2019
BUY
$32.91 - $40.75 $2.98 Million - $3.69 Million
90,598 Added 8.57%
1,147,487 $44 Million
Q4 2018

Feb 12, 2019
BUY
$31.73 - $39.04 $2.47 Million - $3.04 Million
77,960 Added 7.96%
1,056,889 $37.4 Million
Q3 2018

Nov 13, 2018
BUY
$32.83 - $38.63 $5.2 Million - $6.12 Million
158,333 Added 19.29%
978,929 $37.7 Million
Q2 2018

Aug 07, 2018
BUY
$26.84 - $34.32 $3.34 Million - $4.28 Million
124,596 Added 17.9%
820,596 $26.8 Million
Q3 2017

Nov 13, 2017
BUY
$26.26 - $29.17 $1.79 Million - $1.98 Million
68,000 Added 10.83%
696,000 $20.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
628,000
628,000 $17.4 Million

Others Institutions Holding BSX

# of Institutions
1,448
Shares Held
1.21B
Call Options Held
8.14M
Put Options Held
8.3M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email